KI-67 IHC Tumor Proliferation Test | Lahalak Platform
An essential diagnostic assessment to measure how fast cancer cells are proliferating. It provides clear insights into tumor aggressiveness, helping doctors decide on the optimal intensity of treatment.
Scientific name: Immunohistochemistry: KI-67
This predictive consultation package focuses on assessing the proliferative activity of tumor cells. It is based on measuring the KI-67 index, a nuclear protein expressed in all active cell cycle phases (G1, S, G2, M) except for the resting phase (G0). The package also includes complementary proliferative or predictive markers such as p53 (for tumo...
Service type
Laboratory Tissue Analysis
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Examination and measurement of the KI-67 proliferation index in the most active areas of the tumor (Hotspot Analysis).
- Examination of relevant complementary markers (e.g., p53, or ER/PR/HER2 in the context of breast cancer).
- Consultation regarding the interpretation of the KI-67 percentage in the context of tumor type and grade according to standard guidelines.
- Issuing a report summarizing the proliferation index and its clinical implications for treatment decision-making.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- Providing a sufficient and quality tissue mass (paraffin block) that accurately represents the tumor is required.
- It is necessary to include an accurate histological diagnosis of the type of tumor.
- There is no need to fast, as it is a test on a tissue sample.
- Expected duration: 5 to 10 working days.
Medical services you might also like
